Archives
|
Entry
|
Blogger
|
Date
▴
|
Xconomist
|
Location
|
|
Sonus Obtains License From Bayer to Develop Cancer Drugs
|
Luke Timmerman |
08/07/08 |
|
Seattle
|
|
Seattle Genetics Starts Clinical Trial of SGN-70 For Autoimmune Disease
|
Luke Timmerman |
07/31/08 |
|
Seattle
|
|
Dendreon Holds Its Breath, Big Provenge Clinical Trial Result Coming In October
|
Luke Timmerman |
07/31/08 |
|
Seattle
|
|
Ariad Begins Clinical Trial of Breast Cancer Drug
|
Luke Timmerman |
07/30/08 |
|
Boston
|
|
Infinity Pharmaceuticals Starts First Clinical Trial of Oral Hsp-90 Blocker
|
Luke Timmerman |
07/30/08 |
|
Boston
|
|
The Future of Biotech Is in Rabbits, Says Entrepreneur Johnny Stine
|
Luke Timmerman |
07/30/08 |
|
Seattle
|
|
Celator Raises $22.5 Million For Combination Chemo Drugs
|
Luke Timmerman |
07/29/08 |
|
Seattle
|
|
BG Medicine, Targeting Clues in Blood, Aims to Predict Whether a Drug Will Help
|
Luke Timmerman |
07/29/08 |
|
Boston
|
|
Caliper Bets Future on Tools That Light Up Genes Before Researchers’ Eyes
|
Luke Timmerman |
07/28/08 |
|
Boston
|
|
Harvard Stem Cell Institute Wins $25 Million Investment From GlaxoSmithKline
|
Luke Timmerman |
07/25/08 |
|
Boston
|
|
Cell Therapeutics Raises $44.5 Million From Institutional Investor
|
Luke Timmerman |
07/24/08 |
|
Seattle
|
|
Light Sciences Oncology, Led by CEO on the Go, Prepares for Its Big Day
|
Luke Timmerman |
07/24/08 |
|
Seattle
|
|
Dendreon Expects Interim Provenge Trial Results in October
|
Luke Timmerman |
07/23/08 |
|
Seattle
|
|
Infinity Adds Two New Members To Board of Directors
|
Luke Timmerman |
07/22/08 |
|
Boston
|
|
Sonus Pharmaceuticals Holds On To Nasdaq Listing
|
Luke Timmerman |
07/17/08 |
|
Seattle
|
|
Dendreon Starts Trial of Patients With Localized Prostate Cancer
|
Luke Timmerman |
07/16/08 |
|
Seattle
|
|
Predictive Biosciences Hires New Chiefs for Finance, Medicine
|
Luke Timmerman |
07/16/08 |
|
Boston
|
|
Light Sciences Oncology Raises $40 Million for Cancer Trials
|
Luke Timmerman |
07/15/08 |
|
Seattle
|
|
T2 Biosystems Diagnostic Holds Its Own In Comparison Against Hospital Tool
|
Luke Timmerman |
07/15/08 |
|
Boston
|
|
Dicerna Pharmaceuticals Raises Another $8.4 Million for Next-Generation RNAi
|
Luke Timmerman |
07/15/08 |
|
Boston
|
|
Infinity Pharmaceuticals Pulls Plug on Treatment for Prostate Cancer
|
Luke Timmerman |
07/14/08 |
|
Boston
|
|
Sound Pharmaceuticals Applies to Test Drug Against Chemo-Induced Hearing Loss
|
Luke Timmerman |
07/14/08 |
|
Seattle
|
|
Calistoga Starts First Clinical Trial of Cancer Drug
|
Luke Timmerman |
07/10/08 |
|
Seattle
|
|
Cell Therapeutics Gets a Win on Capitol Hill, Zevalin Reimbursement To Remain Same
|
Luke Timmerman |
07/09/08 |
|
Seattle
|
|
Seattle Genetics Licenses Antibody-Drug Linking Technology to Daiichi Sankyo
|
Luke Timmerman |
07/08/08 |
|
Seattle
|
|
Agios, Developer of Drugs That Starve Cancer Cells, Scarfs Up $33 Million in Venture Funds
|
Luke Timmerman |
07/07/08 |
|
Boston
|
|
Calypso Medical’s “GPS For the Body” Gaining Ground With Radiation Doctors
|
Luke Timmerman |
06/25/08 |
|
Seattle
|
|
Seattle Genetics Gunning for the Market With “Empowered Antibody” For Cancer
|
Luke Timmerman |
06/14/08 |
|
Seattle
|
|
BioVex Viral Treatment Shrinks Melanoma Tumors in Trial
|
Luke Timmerman |
06/01/08 |
|
Boston
|
|
Infinity Drug Slows Spread of Deadly Stomach Cancer—FDA Clears Accelerated Trial
|
Luke Timmerman |
05/31/08 |
|
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
